tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $14.78. This is a potential upside of $14.78 (0%) from yesterday's end of day stock price of $0.
Catabasis Pharmaceuticals's activity chart (see below) currently has 14 price targets and 18 ratings on display.
Analysts average stock forecasts to be materialized ratio is 25.83% with an average time for these price targets to be met of 112.5 days.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 24-Aug-2021. First documented stock forecast 19-Jul-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$13
$5.93 (83.88%)
4 years 2 months 1 days ago
(24-Aug-2021)
0/2 (0%)
$3.74 (40.39%)
Buy
$30
$22.93 (324.33%)
4 years 7 months 15 days ago
(10-Mar-2021)
1/3 (33.33%)
$9.24 (44.51%)
63
Buy
$6.9
$-0.17 (-2.40%)
$90
4 years 11 months 24 days ago
(01-Nov-2020)
1/5 (20%)
$-1.26 (-15.44%)
350
Buy
$150
$142.93 (2021.64%)
$90
7 years 11 months 6 days ago
(19-Nov-2017)
1/2 (50%)
$47.4 (46.20%)
37
What is CATB (Catabasis Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CATB (Catabasis Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CATB (Catabasis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CATB (Catabasis Pharmaceuticals)?
Which analyst is the currently most bullish on CATB (Catabasis Pharmaceuticals)?
Which analyst is the currently most reserved on CATB (Catabasis Pharmaceuticals)?
